FDA Inspection 1254089 — Grissel Flores, APN
The FDA completed an inspection of Grissel Flores, APN on Nov 5, 2024 in Newark, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 5, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Newark, NJ (United States)
Additional Details
Clinical BA/BE